# Epoprostenol

NDC: 68083-707
Generic name: Epoprostenol
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20251229

FDA application: ANDA219237

## Active ingredients

- EPOPROSTENOL: .5 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-707"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-707
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=47f64fcd-cbf7-457a-9548-661fb10ff7e0